ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Proteostasis Therapeutics, Inc." (PTI) Report Updated: Apr 22, 2017 | Print This Page

Get more stock ratings by Louis Navellier

"Proteostasis Therapeutics, Inc." (PTI)

Rating: Hold Volatility: Aggressive
Total Grade: C Industry: Biotechnology
Competitors: BPMC,KIN,EXAS,EGRX

Stock Analysis

Rating: Monthly View

A
B
C
D
F
April May June July August September October November December January February March

Rating: Weekly View

This Week: C down no change
Last Week: C same upgrade
Two Weeks Ago: D up downgrade
service keys

"Proteostasis Therapeutics, Inc."© quotemedia

Company Profile